Dry Eye Innovations
Himani Goyal, MD, discusses how advances in dry eye treatments have improved ophthalmic practice and outcomes.
Clinical Scorecard: Dry Eye Innovations
At a Glance
Category Detail
Condition Dry Eye Disease Key Mechanisms Innovative treatments including medications for Demodex and blepharitis, and new ophthalmic solutions. Target Population Patients of all ages experiencing dry eye symptoms. Care Setting Ophthalmology practices, particularly those with specialized dry eye services.
Key Highlights
Introduction of specialized dry eye specialists to enhance patient care. Advancements in medications like lotilaner and perfluorohexyloctane ophthalmic solution. Improved patient comfort and satisfaction with new treatment options. Enhanced visual acuity outcomes for patients with dry eye. Recognition of dry eye as a significant issue across various age groups. Guideline-Based Recommendations
Diagnosis
Utilize a stepwise approach to diagnose dry eye disease. Management
Incorporate new medications and treatments for effective management. Monitoring & Follow-up
Regularly assess patient comfort and visual acuity. Risks
Consider the impact of untreated dry eye on surgical outcomes and quality of life. Patient & Prescribing Data
Individuals suffering from dry eye symptoms, including both young and older patients.
Access to innovative treatments has improved patient outcomes and satisfaction.
Clinical Best Practices
Employ a multidisciplinary approach by involving dry eye specialists. Stay updated on the latest treatment options and their applications. Focus on patient education and comfort in treatment plans. Related Resources & Content
